Overview

Hematopoietic Stem Cell Transplant Survivors Study (HTSS Study)

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Dasatinib
Quercetin